Digitalis Ventures

Our deep technical, financial, and domain expertise combine to help creatively finance, build, and scale enduring enterprises.

We invest in biotechnology companies leveraging breakthrough science to improve human health. Our interests encompass a broad spectrum of the life sciences, from therapeutics and diagnostics to tools and enabling technologies.

We invest in companies building novel technology-enabled solutions to improve access to care and health outcomes while reducing costs to individuals and the healthcare system.

Through our Companion Funds, we invest in companies leveraging breakthrough science, technology, and design to improve animal health.

The Digitalis Press writes and publishes on life sciences, health technologies & services, and animal health.